BeOne Medicines Cash Flow Statement
NASDAQ: ONCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
354.47+4.34 (+1.24%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BeOne Medicines free cash flow
In fiscal 2025, BeOne Medicines generated $1.13 billion of operating cash flow and spent $185.8 million on capital expenditures. That left free cash flow of $941.7 million, a free-cash-flow margin of 17.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
BeOne Medicines cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 286.93M | -644.79M | -881.71M | -2.00B | -1.46B | -1.63B | -950.58M | -674.03M | -93.30M | -119.22M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 141.69M | 171.76M | 87.67M | 66.28M | 46.46M | 31.79M | 18.62M | 10.39M | 4.76M | 1.91M |
| Stock-Based Compensation | 510.86M | 441.62M | 367.62M | 303.16M | 240.71M | 183.48M | 134.15M | 87.13M | 42.86M | 10.63M |
| Change in Working Capital | -120.86M | -268.52M | -550.65M | 86.76M | -258.39M | -34.43M | -88.63M | -41.14M | 23.10M | -433.00K |
| Operating Cash Flow | 1.13B | -140.63M | -1.16B | -1.50B | -1.30B | -1.28B | -750.27M | -547.72M | 12.75M | -89.51M |
| Capital Expenditures | -185.84M | -492.66M | -561.90M | -325.43M | -262.94M | -117.51M | -89.61M | -70.28M | -46.37M | -23.50M |
| Investing Cash Flow | -276.15M | -548.35M | 60.00M | 1.08B | 640.66M | -3.17B | 554.16M | -637.61M | -356.32M | -221.85M |
| Debt Issued | — | — | — | — | — | 433.90M | 67.49M | 42.31M | — | — |
| Debt Repaid | -35.68M | -28.03M | -13.69M | 0 | 0 | -132.06M | -32.81M | -8.74M | 0 | 0 |
| Financing Cash Flow | 1.06B | 193.45M | 416.48M | -18.97M | 3.64B | 5.20B | 85.68M | 1.69B | 490.36M | 380.90M |
| Net Change in Cash | 1.97B | -547.24M | -689.05M | -507.85M | 2.99B | 769.23M | -119.94M | 501.11M | 152.09M | 69.64M |
| Free Cash Flow | 941.74M | -633.29M | -1.72B | -1.82B | -1.56B | -1.40B | -839.88M | -618.00M | -33.62M | -113.02M |
This table shows 10 annual periods of BeOne Medicines's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ONC's reporting calendar. What is a cash flow statement?